Cell therapy for ischemic stroke: Are differences in preclinical and clinical study design responsible for the translational loss of efficacy?
Saved in:
| Title: | Cell therapy for ischemic stroke: Are differences in preclinical and clinical study design responsible for the translational loss of efficacy? |
|---|---|
| Authors: | Cui, Li‐li1,2 (AUTHOR), Golubczyk, Dominika3 (AUTHOR), Tolppanen, Anna‐Maija4 (AUTHOR), Boltze, Johannes5 (AUTHOR), Jolkkonen, Jukka2,6 (AUTHOR) jukka.jolkkonen@uef.fi, Cui, Li-Li7,8 (AUTHOR), Tolppanen, Anna-Maija9 (AUTHOR) |
| Source: | Annals of Neurology. Jul2019, Vol. 86 Issue 1, p5-16. 12p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 136997147 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Cell therapy for ischemic stroke: Are differences in preclinical and clinical study design responsible for the translational loss of efficacy? – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Cui%2C+Li‐li%22">Cui, Li‐li</searchLink><relatesTo>1,2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Golubczyk%2C+Dominika%22">Golubczyk, Dominika</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Tolppanen%2C+Anna‐Maija%22">Tolppanen, Anna‐Maija</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Boltze%2C+Johannes%22">Boltze, Johannes</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Jolkkonen%2C+Jukka%22">Jolkkonen, Jukka</searchLink><relatesTo>2,6</relatesTo> (AUTHOR)<i> jukka.jolkkonen@uef.fi</i><br /><searchLink fieldCode="AR" term="%22Cui%2C+Li-Li%22">Cui, Li-Li</searchLink><relatesTo>7,8</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Tolppanen%2C+Anna-Maija%22">Tolppanen, Anna-Maija</searchLink><relatesTo>9</relatesTo> (AUTHOR) – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Annals+of+Neurology%22">Annals of Neurology</searchLink>. Jul2019, Vol. 86 Issue 1, p5-16. 12p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=136997147 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1002/ana.25493 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 12 StartPage: 5 Titles: – TitleFull: Cell therapy for ischemic stroke: Are differences in preclinical and clinical study design responsible for the translational loss of efficacy? Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Cui, Li‐li – PersonEntity: Name: NameFull: Golubczyk, Dominika – PersonEntity: Name: NameFull: Tolppanen, Anna‐Maija – PersonEntity: Name: NameFull: Boltze, Johannes – PersonEntity: Name: NameFull: Jolkkonen, Jukka – PersonEntity: Name: NameFull: Cui, Li-Li – PersonEntity: Name: NameFull: Tolppanen, Anna-Maija IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 07 Text: Jul2019 Type: published Y: 2019 Identifiers: – Type: issn-print Value: 03645134 Numbering: – Type: volume Value: 86 – Type: issue Value: 1 Titles: – TitleFull: Annals of Neurology Type: main |
| ResultId | 1 |